EMBioSys is invited to present at NCI’s first Cancer Bioelectricity Conference

EMBioSys is honored to announce that our President and Chief Scientific Officer, Dr. Vish Subramaniam, has been asked to present at the Cancer Bioelectricity Conference sponsored by the National Cancer Institute on September 12th, 2024. 

Dr. Subramaniam will be speaking about “Technologies for treatment of Metastatic Solid Tumors”, including EMBioSys’ iEF Therapy.  One of the key goals of the conference is to disseminate the science of bioelectricity and its potential applications towards cancer treatments to a diverse audience.  The National Cancer Institute’s support for research and development of bioelectricity is an important step in the evolution of life-saving technologies for cancer patients in the future.

Link to the event: https://dctd.cancer.gov/about/news-events/events/past-events/bioelectricity-cancer-conference